The present findings reiterate that increased E-Selectin, a marker of vascular injury, is associated with increased T2D risk, while higher circulating thrombomodulin levels, indicative of vessel protection, may be related to a decreased risk of developing T2D. The gene discussed is THBD; the disease is type 2 diabetes mellitus.